Researchers have applied a novel method of vaccine creation for Chikungunya virus using a technique called large scale random codon re-encoding. Using this approach, scientists have demonstrated that the engineered viruses exhibit a stable phenotype with a significantly decreased viral fitness, making it a new vaccine candidate for this emerging viral disease.